enVVeno Medical Corporation Share Price & Technical Analysis
NVNO · $10.96 (+0.55%)
Healthcare / Medical Devices
$10.96
+0.55%
enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of t…
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
-4% return in May, -8% avg return in past 3 year May month.
-20% return in 2026, -49% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 3% | -17% | -1% | -1% | -4% | – | – | – | – | – | – | – | -20% |
| 25 | 9% | 0% | -20% | 14% | 19% | 8% | 16% | -82% | 7% | -23% | -47% | -16% | -116% |
| 24 | -19% | 41% | -16% | -2% | -10% | 8% | 2% | -2% | -36% | -4% | -9% | -6% | -53% |
| 23 | 10% | 1% | -19% | -12% | -34% | 6% | 63% | -2% | 7% | -20% | -23% | 46% | 23% |
| 22 | -18% | -10% | 26% | -26% | -9% | -7% | 41% | 41% | -13% | 0% | -6% | -12% | 7% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$6.41M
P/E ratio
—
52W high
$196.7
52W low
$8.67
Volume
11,453
Beta
1.08
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is enVVeno Medical Corporation share price today?
- enVVeno Medical Corporation (NVNO) last traded around $10.96 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does NVNO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for NVNO. Download the app for real-time alerts.
- How can I analyze enVVeno Medical Corporation stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.